Drug kills cancer cells by restoring faulty tumor suppressor
Monday, May 14, 2012 - 15:31
in Health & Medicine
New research uses a novel, computer based strategy to identify potential anti-cancer drugs, including one that targets the third most common p53 mutation in human cancer, p53-R175H. The number of new cancer patients harboring this mutation in the United States who would potentially benefit from this drug is estimated to be 30,000 annually.